CSH Pharma Group

CSH Pharma Group operates within the Pharmaceutical and Healthcare sectors, focusing on state-of-the-art medicine manufacturing for national and international markets. The company engages in strategic collaborations with prominent pharmaceutical entities such as Novartis - Sandoz and GETZ Pharma, facilitating the production of their select brand portfolios. This B2B manufacturing capability underscores its role in the broader pharmaceutical supply chain, adhering to quality standards for diverse therapeutic areas. The company's product focus is primarily on pharmaceuticals, serving critical healthcare needs through its production facilities. With an employee range of 500 - 1,000 individuals, CSH Pharma Group demonstrates significant operational capacity. The company generates an annual revenue of $22.7M. Beyond manufacturing, CSH Pharma Group extends its reach through a chain of community and institutional pharmacies, staffed by qualified professionals operating within controlled and regulated environments. Meet CSH Pharma Group's team to understand the expertise driving these diverse operations. The group's business model encompasses both high-quality pharmaceutical production and direct patient care via its pharmacy network. Its presence in Asia, specifically Pakistan, serves as a base for its regional and international endeavors. The company's commitment to quality is evident in its manufacturing processes and its regulated pharmacy operations, catering to diverse healthcare needs.